Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2014
02/13/2014WO2014022936A1 Chlamydia antigen compositions and uses thereof
02/13/2014WO2014022924A1 A method for the induction of an immune response
02/13/2014WO2013191591A9 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae
02/13/2014WO2013181495A3 Compositions comprising an anti-pdgf aptamer and a vegf antagonist
02/13/2014WO2013177596A3 Methods for treating gi syndrome and graft versus host disease
02/13/2014WO2013177283A3 Disulfide stabilized foldon polypeptides
02/13/2014WO2013173542A4 Methods for treating cancer with notch2/3 antibodies
02/13/2014WO2013164789A3 Lyophilised and aqueous anti-cd40 antibody formulations
02/13/2014WO2013014408A8 Vaccine
02/13/2014US20140045843 Methods of treating cancer using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
02/13/2014US20140044771 Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof
02/13/2014US20140044752 Inactivated virus compositions and methods of preparing such compositions
02/13/2014US20140044751 Rsv immunization regimen
02/13/2014US20140044749 Vaccines against clostridium difficile and methods of use
02/13/2014US20140044748 Methods for preparing complex multivalent immunogenic conjugates
02/13/2014US20140044747 Combination vaccine
02/13/2014US20140044743 Method for enhancing immune response with peptide
02/13/2014US20140044741 B-type plexin antagonists and uses thereof
02/13/2014US20140044738 Antibodies And Other Molecules That Bind B7-H1 And PD-1
02/13/2014US20140044736 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
02/13/2014US20140044734 Method for treating liver inflammation, fibrosis and non-alcoholic steatohepatitis
02/13/2014US20140044731 Methods of treating age-related macular degeneration
02/13/2014US20140044729 Antibody and antigen recognizing tumor-initiating cells and use thereof
02/13/2014US20140044727 Formulations with reduced viscosity
02/13/2014US20140044725 Alzheimer's disease treatment method
02/13/2014US20140044722 Anti-sod1 antibodies and uses thereof
02/13/2014US20140044715 Treating allergic airway disorders using anti-il-20 receptor antibodies
02/13/2014US20140044714 Human monoclonal antibodies specific for glypican-3 and use thereof
02/13/2014US20140044713 Compounds
02/13/2014US20140044712 Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments
02/13/2014US20140044710 Von willebrand factor specific binders and methods of use therefor
02/13/2014US20140044709 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
02/13/2014US20140044705 Combination therapy of an afucosylated cd20 antibody with bendamustine
02/13/2014US20140044704 Treatment of metastatic breast cancer
02/13/2014US20140044702 Diagnosis and treatments relating to th2 inhibition
02/13/2014US20140044645 Diagnosis and treatments relating to th2 inhibition
02/13/2014US20140044644 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
02/13/2014US20140044641 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
02/13/2014US20140044640 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
02/13/2014US20140044639 Antibody Therapy
02/13/2014DE10329087B4 Antigenhaltige Mikrosphären zur Allergietherapie Antigen-containing microspheres for allergy therapy
02/12/2014EP2695947A1 Recombinant polypeptide production method
02/12/2014EP2695941A2 Novel immunoadjuvant flagellin-based compounds and use thereof
02/12/2014EP2695895A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
02/12/2014EP2695892A1 Peptide which can induce antibody capable of recognizing stereostructure of hiv
02/12/2014EP2694708A2 Formulations with reduced viscosity
02/12/2014EP2694654A1 Protease cleavage site peptides as an hiv vaccine
02/12/2014EP2694551A1 Anti-fgfr4 antibodies and methods of use
02/12/2014EP2694544A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
02/12/2014EP2694542A2 Herpes simplex virus
02/12/2014EP2694540A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
02/12/2014EP2694534A1 Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
02/12/2014EP2694533A2 Method of inducing neutralizing antibodies to human immunodeficiency virus
02/12/2014EP2694108A2 Methods for treating conditions associated with masp-2 dependent complement activation
02/12/2014EP2694107A2 Treatment for dermatological pathologies
02/12/2014EP2694106A2 Methods for increasing efficacy of folr1 cancer therapy
02/12/2014EP2694105A2 Cd37-binding molecules and immunoconjugates thereof
02/12/2014EP2694104A1 Process for producing an immunogenic composition containing tetanus toxoid
02/12/2014EP2694103A1 Non-self t-cell epitope fused to an antibody that recognises a tumour-specific cell-surface receptor and uses thereof
02/12/2014EP2694102A2 Methods of improving vaccine immunogenicity
02/12/2014EP2694101A2 Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
02/12/2014EP2694100A1 Formulations with reduced viscosity
02/12/2014EP2694099A1 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
02/12/2014EP2694094A1 Method for treating ifnalpha related conditions
02/12/2014CN103582724A Formulations with reduced viscosity
02/12/2014CN103582651A Monoclonal antibody capable of recognizing human papilloma virus (HPV) L2 protein, and method for measuring HPV-neutralizing antibody titer using same
02/12/2014CN103582494A Compositions targeting the soluble extracellular domain of E-cadherin and related methods for cancer therapy
02/12/2014CN103582493A Eye-drop-type vaccine for avian influenza
02/12/2014CN103582492A Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
02/12/2014CN103571873A Recombinant adenovirus as well as preparation method and application thereof
02/12/2014CN103571867A Brucella melitensis recombination strain M5-delta znuA and preparation method and applications thereof
02/12/2014CN103571848A Virulence gene of punctate palmoplantar keratodermas and use thereof
02/12/2014CN103571799A Duck-sourced H4N6 subtype avian influenza virus strain and application thereof
02/12/2014CN103571798A Duck tembusu virus low virulent strain and application thereof
02/12/2014CN103571797A Hog cholera cell adaptive virus, hog cholera virus live vaccine prepared from hog cholera cell adaptive virus, and preparation method of hog cholera virus live vaccine
02/12/2014CN103570835A Staphylococcus aureus ITC (Inverse Transition Cycling) fusion protein as well as preparation method and application thereof
02/12/2014CN103570832A Anti-Haemophilus parasuis porcine chimeric antibody, and construction method and application thereof
02/12/2014CN103570831A Bovine-derived anti-staphylococcus aureus single-chain antibody as well as preparation method and application thereof
02/12/2014CN103570821A Mucin-1 antigenic polypeptide and application thereof as tumor vaccine
02/12/2014CN103570818A Tumor antigenic polypeptide and application thereof as tumor vaccine
02/12/2014CN103566378A Tumor nucleic acid vaccine based on tissue factor as well as preparation method and application of vaccine
02/12/2014CN103566377A Targeted immunotherapy for cancer
02/12/2014CN103566370A Preparation method and application of swine vaccine specific swine spleen transfer factor (TF)
02/12/2014CN103566369A Hepatitis B vaccine for inducing organism to generate specific immunity in state of chronic hepatitis B virus infection
02/12/2014CN103566368A Sheet-like preparation containing allergen and manufacturing method thereof
02/12/2014CN103566367A Oral allergen vaccine as well as preparation and application thereof
02/12/2014CN103566366A Preparation method of Newcastle disease oil-in-water-in-oil type inactivated vaccine for broilers
02/12/2014CN103566365A Haemophilus parasuis disease and swine pasteurella multocida disease combined vaccine and preparation method thereof
02/12/2014CN103566364A Porcine contagious pleuropneumonia and streptococcus suis disease combined inactivated vaccine and preparation method thereof
02/12/2014CN103565834A Preparation method and application of swine vaccine specific cattle spleen transfer factor (TF)
02/12/2014CN102238962B Anti-ferroportin 1 monoclonal antibodies and uses thereof
02/12/2014CN101918442B Anti-VEGF antibodies
02/12/2014CN101730543B Inactivated staphylococcal whole-cell vaccine
02/12/2014CN101704892B Anti-uPAR humanized antibody, coding gene and application thereof
02/12/2014CN101702906B Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
02/12/2014CN101646459B Chronic rejection inhibitor
02/11/2014US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof
02/11/2014US8648052 Prevention of chlamydia infection using SIRNA
02/11/2014US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/11/2014US8647818 Molecular scaffolds for HIV-1 immunogens
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 1823